Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01426217 · ClinicalTrials.gov registry record · NA
Reduction in IV Associated Contamination
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 594
- Enrollment target
NCT01426217 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 594 participants.
The verdict
NCT01426217, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 594 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether implementing a novel syringe and IV stopcock cap system impregnated with alcohol will reduce IV catheter bacterial contamination and infections in patients.
Interventions
- DEVICE Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 594 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01426217
The ClinicalTrials.gov registry entry for NCT01426217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 594 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt is the first listed.
NCT01426217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01426217 about?
NCT01426217 is a clinical study titled "Reduction in IV Associated Contamination". The purpose of this study is to investigate whether implementing a novel syringe and IV stopcock cap system impregnated with alcohol will reduce IV catheter bacterial contamination and infections in patients.
What is the current status of trial NCT01426217?
This trial is currently completed. It is a NA study. The enrollment target is 594 participants. The study started on 2011-08. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01426217?
The interventions under investigation include: Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt (DEVICE).
Who is sponsoring clinical trial NCT01426217?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.